Korean J Obstet Gynecol Search

CLOSE


Obstet Gynecol Sci > Volume 52(12); 2009 > Article
Korean Journal of Obstetrics & Gynecology 2009;52(12):1258-1264.
Published online: December 1, 2009
A study for diagnosis of squamous cell carcinoma arising from mature cystic teratoma.
Hyun Young Ji, Tae Joong Kim, Min Jae Kim, Eun Joo Lee, Yoo Young Lee, Chul Jung Kim, Chel Hun Choi, Jeong Won Lee, Byoung Gie Kim, Duk Soo Bae
Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. bgkim@skku.edu
Abstract
OBJECTIVE
To evaluate factors for diagnosis of squamous cell carcinoma arising from ovarian mature cystic teratoma and whether squamous cell carcinoma (SCC) antigen, CA125, CA19-9 and CEA is useful for detection of the malignant transformation of mature cystic teratoma of ovary. METHODS: From October 1999 to December 2008, 11 patients with malignant transformation arising from ovarian mature cystic teratoma were treated at Departments of Obstetric and Gynecology in Samsung Medical Center. Demographic characteristics, symptoms, sign, preoperative images, stage, mode of therapy and results of follow up were reviewed retrospectively. RESULTS: The incidence of squamous cell carcinoma arising from ovarian mature cystic teratoma was 0.15% (11/7,345) in this hospital. The median age of patients was 60.8 years (range, 48~73 years). The most common preoperative diagnosis is mature cystic teratoma (n=5), followed by malignant transformation of mature cystic teratoma (n=3), colon cancer (n=2), primary epithelial ovarian cancer (n=1). SCC antigen level was elevated in five patients (45.4%) and CA125 was elevated in seven patients (63.6%). Median longitudinal diameter of ovarian tumors was 11.1 cm. All the patients were surgically staged. CONCLUSION: We should consider women, old aged and had large sized ovarian teratoma, were associated with development of malignant transformation of ovarian mature cystic teratomas, especially squamous cell carcinoma. CEA, CA19-9, and SCC antigen, in addition to CA125, should be used for tumor markers.
Keywords: Mature cystic teratoma; Squamous cell carcinoma; SCC antigen; Ovary
TOOLS
  • Full text via DOI   Full text via DOI
  • Download Citation Download Citation
Share :
Facebook Twitter Linked In Google+ Line it
METRICS Graph View
  • 1,687 View
  • 10 Download
Related articles in Obstet Gynecol Sci

The study on the nucleolar organizer regions in squamous cell carcinoma of the uterine cervix.1991 September;34(9)

A case of primary squamous cell carcinoma of vagina.1992 March;35(3)

Two cases of squamous cell carcinoma arising from benign teratomaas of ovary.1992 August;35(8)

Two cases of squmous cell carcinoma arising in benign teratoma of the ovary.1993 July;36(7)

Squamous carcinoma arising in benign cystic teratoma.1993 July;36(7)



ABOUT
ARTICLE & TOPICS
Article category

Browse all articles >

Topics

Browse all articles >

BROWSE ARTICLES
POLICY
FOR CONTRIBUTORS
Editorial Office
4th Floor, 36 Gangnam-daero 132-gil, Gangnam-gu, Seoul 06044, Korea.
Tel: +82-2-2271-6788    Fax: +82-2-3445-2440    E-mail: journal@ogscience.org                

Copyright © 2026 by Korean Society of Obstetrics and Gynecology.

Developed in M2PI

Close layer
prev next